Q1 2023 Holdings
Filed 2023-05-15 | 41 holdings | $333.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Harrow Health Inc(HROW) | COM | 415858109 | $79.9M | 3,775,000 | 23.9% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $32.2M | 6,105,900 | 9.6% |
| Tela BIO Inc(TELA) | COM | 872381108 | $22.1M | 2,072,813 | 6.6% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $13.1M | 735,000 | 3.9% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $12.6M | 785,794 | 3.8% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $10.9M | 2,810,800 | 3.3% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $10.2M | 238,000 | 3.0% |
| Tracon Pharmaceuticals Inc | COM NEW | 89237H209 | $9.0M | 4,764,508 | 2.7% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $8.4M | 2,185,000 | 2.5% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $8.1M | 2,692,594 | 2.4% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $7.4M | 540,000 | 2.2% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $7.3M | 207,500 | 2.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $7.3M | 923,200 | 2.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $6.6M | 177,000 | 2.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $6.3M | 1,401,000 | 1.9% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $5.9M | 546,304 | 1.8% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $5.5M | 502,000 | 1.7% |
| 4D Molecular Therapeutics Inc(FDMT) | COM | 35104E100 | $5.4M | 314,000 | 1.6% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $5.3M | 2,880,000 | 1.6% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $5.3M | 765,000 | 1.6% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $5.1M | 243,000 | 1.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $5.0M | 750,000 | 1.5% |
| Morphosys AG | SPONSORED ADS | 617760202 | $4.7M | 1,194,000 | 1.4% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $4.7M | 343,000 | 1.4% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $4.7M | 505,000 | 1.4% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $4.3M | 488,100 | 1.3% |
| Edap TMS S A(EDA) | SPONSORED ADR | 268311107 | $4.2M | 382,400 | 1.3% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $4.1M | 302,000 | 1.2% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $4.0M | 575,200 | 1.2% |
| Fortress Biotech Inc | COM | 34960Q109 | $3.8M | 4,573,600 | 1.1% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $3.5M | 496,000 | 1.1% |
| Codexis Inc(CDXS) | COM | 192005106 | $3.1M | 750,000 | 0.9% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $2.6M | 421,000 | 0.8% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $2.1M | 125,500 | 0.6% |
| Kezar Life Sciences Inc | COM | 49372L100 | $2.0M | 625,000 | 0.6% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $1.8M | 115,000 | 0.5% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $1.8M | 867,100 | 0.5% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $1.5M | 835,800 | 0.5% |
| Proqr Therapeutics NV | SHS EURO | N71542109 | $1.4M | 653,000 | 0.4% |
| Nyxoah S A(NYXH) | SHS | B6S7WD106 | $430.2K | 57,585 | 0.1% |
| Modular Medical Inc(MODD) | COM NEW | 60785L207 | $266.1K | 183,500 | 0.1% |